These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


173 related items for PubMed ID: 15934969

  • 21. Genetic determinants of cardiovascular disease risk in familial hypercholesterolemia.
    Jansen AC, van Aalst-Cohen ES, Tanck MW, Cheng S, Fontecha MR, Li J, Defesche JC, Kastelein JJ.
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1475-81. PubMed ID: 15879303
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Genetic polymorphisms of hypoxia-inducible factor-1 alpha and cardiovascular disease in hemodialysis patients.
    Zheng ZL, Hwang YH, Kim SK, Kim S, Son MJ, Ro H, Sung SA, Lee HH, Chung WK, Joo KW, Yang J.
    Nephron Clin Pract; 2009 Jul; 113(2):c104-11. PubMed ID: 19602906
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Anemia and the heart in chronic kidney disease.
    Zalunardo N, Levin A.
    Semin Nephrol; 2006 Jul; 26(4):290-5. PubMed ID: 16949467
    [Abstract] [Full Text] [Related]

  • 26. Association between oestrogen receptor alpha gene polymorphism and mortality in female end-stage renal disease patients.
    Kato S, Lindholm B, Axelsson J, Qureshi RA, Barany P, Heimbürger O, Gustafsson JA, Stenvinkel P, Nordfors L.
    Nephrol Dial Transplant; 2007 Sep; 22(9):2571-7. PubMed ID: 17452407
    [Abstract] [Full Text] [Related]

  • 27. Excess mortality due to interaction between protein-energy wasting, inflammation and cardiovascular disease in chronic dialysis patients.
    de Mutsert R, Grootendorst DC, Axelsson J, Boeschoten EW, Krediet RT, Dekker FW, NECOSAD Study Group.
    Nephrol Dial Transplant; 2008 Sep; 23(9):2957-64. PubMed ID: 18400817
    [Abstract] [Full Text] [Related]

  • 28. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
    Paik JK, Kim OY, Koh SJ, Jang Y, Chae JS, Kim JY, Kim HJ, Hyun YJ, Cho JR, Lee JH.
    Clin Chim Acta; 2007 May 01; 380(1-2):68-74. PubMed ID: 17335789
    [Abstract] [Full Text] [Related]

  • 29. Plasma parathyroid hormone level and prevalent cardiovascular disease in CKD stages 3 and 4: an analysis from the Kidney Early Evaluation Program (KEEP).
    Bhuriya R, Li S, Chen SC, McCullough PA, Bakris GL.
    Am J Kidney Dis; 2009 Apr 01; 53(4 Suppl 4):S3-10. PubMed ID: 19285609
    [Abstract] [Full Text] [Related]

  • 30. Contribution of clinical correlates and 13 C-reactive protein gene polymorphisms to interindividual variability in serum C-reactive protein level.
    Kathiresan S, Larson MG, Vasan RS, Guo CY, Gona P, Keaney JF, Wilson PW, Newton-Cheh C, Musone SL, Camargo AL, Drake JA, Levy D, O'Donnell CJ, Hirschhorn JN, Benjamin EJ.
    Circulation; 2006 Mar 21; 113(11):1415-23. PubMed ID: 16534007
    [Abstract] [Full Text] [Related]

  • 31. Role of pulse pressure on cardiovascular risk in chronic kidney disease patients.
    Fernandez-Fresnedo G, Rodrigo E, de Francisco AL, de Castro SS, Castañeda O, Arias M.
    J Am Soc Nephrol; 2006 Dec 21; 17(12 Suppl 3):S246-9. PubMed ID: 17130269
    [Abstract] [Full Text] [Related]

  • 32. Association of single nucleotide polymorphisms on chromosome 9p21.3 with cardiovascular death in kidney transplant recipients.
    Melk A, Schildhorn C, Hömme M, Knoch M, Schmidt BM, Serth J, Scherer S, Döhler B, Opelz G.
    Transplantation; 2013 Apr 15; 95(7):928-32. PubMed ID: 23388737
    [Abstract] [Full Text] [Related]

  • 33. [Analyses of genetic risk factors associated to chronic nephropathy of renal transplant: genetic polymorphisms of cytokynes, adhesion molecules, platelet-coagulation system and cardiovascular risk markers].
    Cobo M, Barrios Y, Iñigo P, Bigo C, Alvarez A, Martín B, Campistol JM, Hernández D, Salido E, Torres A.
    Nefrologia; 2004 Apr 15; 24 Suppl 4():49-56. PubMed ID: 15279387
    [No Abstract] [Full Text] [Related]

  • 34. VEGF -460 genotype plays an important role in progression to chronic kidney disease stage 5.
    Summers AM, Coupes BM, Brennan MF, Ralph SA, Short CD, Brenchley PE.
    Nephrol Dial Transplant; 2005 Nov 15; 20(11):2427-32. PubMed ID: 16046504
    [Abstract] [Full Text] [Related]

  • 35. Genome-wide association studies in nephrology research.
    Köttgen A.
    Am J Kidney Dis; 2010 Oct 15; 56(4):743-58. PubMed ID: 20728256
    [Abstract] [Full Text] [Related]

  • 36. Familial clustering of chronic kidney disease.
    Satko SG, Sedor JR, Iyengar SK, Freedman BI.
    Semin Dial; 2007 Oct 15; 20(3):229-36. PubMed ID: 17555489
    [Abstract] [Full Text] [Related]

  • 37. Associations between USF1 gene variants and cardiovascular risk factors in the Quebec Family Study.
    Choquette AC, Bouchard L, Houde A, Bouchard C, Pérusse L, Vohl MC.
    Clin Genet; 2007 Mar 15; 71(3):245-53. PubMed ID: 17309647
    [Abstract] [Full Text] [Related]

  • 38. Monocyte chemoattractant protein-1 (MCP-1) gene polymorphism as a potential risk factor for cardiovascular disease in hemodialyzed patients.
    Buraczynska M, Bednarek-Skublewska A, Buraczynska K, Ksiazek A.
    Cytokine; 2008 Dec 15; 44(3):361-5. PubMed ID: 19014891
    [Abstract] [Full Text] [Related]

  • 39. Risk factors and underlying cardiovascular diseases in incident ESRD patients.
    Di Benedetto A, Marcelli D, D'Andrea A, Cice G, D'Isa S, Cappabianca F, Pacchiano G, D'Amato R, Oggero AR, Bonanno D, Pergamo O, Calabrò R.
    J Nephrol; 2005 Dec 15; 18(5):592-8. PubMed ID: 16299687
    [Abstract] [Full Text] [Related]

  • 40. [Epidemiology of cardiovascular risk in Chinese chronic kidney disease patients].
    Hou FF, Ma ZG, Mei CL, Rong S, Huang SM, Liu XR, Yuan WJ, Guo YS, Wang L, He Q, Wang XL, Sang XH, Li XL.
    Zhonghua Yi Xue Za Zhi; 2005 Mar 23; 85(11):753-9. PubMed ID: 15949381
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.